Bílik, T.; Vysloužil, J.; Naiserová, M.; Muselík, J.; Pavelková, M.; Mašek, J.; Čopová, D.; Čulen, M.; Kubová, K.
Exploration of Neusilin® US2 as an Acceptable Filler in HPMC Matrix Systems—Comparison of Pharmacopoeial and Dynamic Biorelevant Dissolution Study. Pharmaceutics 2022, 14, 127.
https://doi.org/10.3390/pharmaceutics14010127
AMA Style
Bílik T, Vysloužil J, Naiserová M, Muselík J, Pavelková M, Mašek J, Čopová D, Čulen M, Kubová K.
Exploration of Neusilin® US2 as an Acceptable Filler in HPMC Matrix Systems—Comparison of Pharmacopoeial and Dynamic Biorelevant Dissolution Study. Pharmaceutics. 2022; 14(1):127.
https://doi.org/10.3390/pharmaceutics14010127
Chicago/Turabian Style
Bílik, Tomáš, Jakub Vysloužil, Martina Naiserová, Jan Muselík, Miroslava Pavelková, Josef Mašek, Drahomíra Čopová, Martin Čulen, and Kateřina Kubová.
2022. "Exploration of Neusilin® US2 as an Acceptable Filler in HPMC Matrix Systems—Comparison of Pharmacopoeial and Dynamic Biorelevant Dissolution Study" Pharmaceutics 14, no. 1: 127.
https://doi.org/10.3390/pharmaceutics14010127
APA Style
Bílik, T., Vysloužil, J., Naiserová, M., Muselík, J., Pavelková, M., Mašek, J., Čopová, D., Čulen, M., & Kubová, K.
(2022). Exploration of Neusilin® US2 as an Acceptable Filler in HPMC Matrix Systems—Comparison of Pharmacopoeial and Dynamic Biorelevant Dissolution Study. Pharmaceutics, 14(1), 127.
https://doi.org/10.3390/pharmaceutics14010127